We earn commissions from brands listed on this site, which influences how listings are presented. Advertising Disclosure

AgelessRx

AgelessRx vs Embody

Side-by-side comparison of pricing, physician credentials, pharmacy standards, and lab monitoring protocols.

Embody
AgelessRx

AgelessRx

8.9 Very GoodVisit AgelessRx
Embody

Embody

9.8 OutstandingVisit Embody
CriteriaAgelessRxEmbody
Starting Price$99/mo$99/mo
Our Score8.9 Very Good9.8 Outstanding
Best ForLongevity-focused telehealth with sermorelin as an injection or intranasal spraySermorelin and bioidentical hormone therapy for women's health optimization
BadgeNasal Spray OptionEditor's Pick
No Insurance NeededBioidentical HRT
Fully OnlineNo Insurance Needed
Nasal Spray AvailableFully Online

AgelessRx

Longevity-focused telehealth with sermorelin as an injection or intranasal spray

Pros

  • Lowest published entry price of any provider offering a nasal delivery form
  • Intranasal option at 1000 mcg/mL for patients who will not self-inject
  • No membership or consultation fee layered on top of medication cost
  • 503A compounding pharmacies disclosed publicly, with all 50 states served

Cons

  • Baseline IGF-1 testing is not required before prescribing and labs are not included
  • Asynchronous intake only, with no live video consultation option
  • Cold-shipped injectables are not reliably deliverable to Alaska or Hawaii
Visit AgelessRx

Embody

Sermorelin and bioidentical hormone therapy for women's health optimization

Pros

  • Specialist focus on female hormone optimization
  • Sermorelin combined with bioidentical HRT options
  • Full female hormone panel at intake
  • Providers experienced in perimenopause and menopause protocols

Cons

  • Protocol design takes longer due to comprehensive female hormone evaluation
  • Limited availability in some states
Visit Embody

Overview

AgelessRx[1] and Embody[2] both start at $99 per month and both offer a route around daily subcutaneous injection. AgelessRx does it with an intranasal spray at 1000 mcg/mL[3]; Embody with a daily tablet alongside a weekly injection[2]. Same entry price, different clinical context: Embody builds around female hormone optimization, AgelessRx around a general longevity catalog.

At a Glance

MetricAgelessRxEmbody
Starting price$99/mo injection, $199/mo nasalFrom $99/mo, injection or tablet
Non-injection formIntranasal spray at $199/moDaily tablet at the same $99/mo
Baseline labsNot required, not includedNo bloodwork required
Clinical focusLongevity catalog, men and women 30+Women's hormone optimization with bioidentical HRT
Consumer termsCancel on 48h notice, no minimum term100% refund if not eligible, no price increases

Key Differences

Two different ways around the needle

Embody offers a weekly injection or a daily tablet from $99 per month[2]. AgelessRx offers a daily subcutaneous injection at $99 or the intranasal spray at $199 per month[3]. Embody keeps the non-injection form at the same price. AgelessRx charges double for it. If avoiding injection is the whole point, Embody is the cheaper solution to that problem. The AgelessRx nasal route does have one practical edge: no cold-chain requirement, which matters for Alaska and Hawaii patients where its cold-shipped injectables are unreliable.

Neither one requires baseline labs, and both should

Embody states plainly that no bloodwork is required[2]. AgelessRx does not require a baseline IGF-1 either and does not include labs in the price. This is a shared weakness, not a differentiator. Baseline IGF-1 before prescribing is the correct standard for a GHRH analog, because the IGF-1 response is the measurable output of GH axis stimulation[4] and there is no other way to judge whether 100 mcg/day or 300 mcg/day is the right dose. A patient choosing either platform should plan on independent testing at baseline and at 90 days.

Clinical focus and consumer terms

Embody prescribes sermorelin alongside bioidentical estrogen and progesterone protocols with a female hormone panel at intake, and offers a 100% refund if not eligible, cancel-anytime, and no price increases[2]. AgelessRx sits inside a longevity catalog covering metformin, low-dose naltrexone, rapamycin, and NAD+, with no membership fee, free shipping, cancel-anytime on 48 hours notice, and no minimum term. The terms are close enough that they do not decide this one. What decides it is that Embody holds the $99 price on its non-injection form while the AgelessRx nasal spray costs $199, and Embody runs a female hormone panel at intake that AgelessRx does not.

In Depth

Same entry price, different cost to skip the needle

Both start at $99 per month. Embody holds that price across a weekly injection or a daily tablet[2], so the non-injection route costs nothing extra. AgelessRx charges $99 per month for the daily subcutaneous injection and $199 per month for the intranasal spray at 1000 mcg/mL[3]. For a patient whose only requirement is avoiding injection, Embody solves it at half the AgelessRx price.

A shared weakness worth naming

Embody states no bloodwork is required[2]. AgelessRx does not require baseline IGF-1 either and does not include labs. Neither platform meets the standard here. Sermorelin stimulates the pituitary as a GHRH analog under somatostatin feedback, and IGF-1 is the measurable response[4]. Without a baseline, neither prescribing physician can distinguish a non-responder from an under-dosed patient at the 90-day mark. Plan on independent testing at either provider.

Female hormone context against a longevity catalog

Embody prescribes sermorelin against a full female hormone panel at intake and alongside bioidentical estrogen and progesterone protocols, which is the right build for a woman managing GH decline through perimenopause. AgelessRx sits inside a longevity catalog covering metformin, low-dose naltrexone, rapamycin, and NAD+, and prescribes to men and women aged 30 and over. Different clinical contexts, not different quality tiers.

Consumer terms, side by side

Embody offers a 100% refund if not eligible, cancel-anytime, and no price increases[2]. AgelessRx charges no membership fee, ships free, and allows cancellation on 48 hours notice with no minimum term. Neither locks a patient into a term, which matters on a therapy that takes 6 months to judge. The price protection is the one real asymmetry: Embody commits to no increases, and AgelessRx makes no equivalent commitment on a protocol a patient may run for a year or more.

Choose AgelessRx if

AgelessRx fits a patient, male or female, aged 30 or over who wants sermorelin as part of a broader longevity protocol, or who specifically wants the intranasal delivery form[3] rather than an oral tablet. The nasal form costs $199 per month, so it is a preference decision rather than a value one.

Visit AgelessRx

Choose Embody if

Embody is the better fit for a woman managing GH decline alongside perimenopausal or menopausal hormone shifts, with sermorelin prescribed against a full female hormone panel and a 100% refund if not eligible[2]. Its non-injection form costs the same $99 as the injection, which AgelessRx cannot match.

Visit Embody

Bottom line

At the same $99 entry, Embody delivers the non-injection option without a price premium and evaluates female hormones properly. AgelessRx offers the only intranasal route and a wider longevity catalog. Both skip baseline IGF-1, so budget for your own labs at baseline and at 90 days either way.

Frequently Asked Questions

Which non-injection form is better, a nasal spray or a daily tablet?

Both bypass subcutaneous administration and both absorb differently from the 100 to 300 mcg/day subcutaneous reference dose, so the prescribing physician sets the dose for the chosen route. The practical difference is cost: Embody keeps the daily tablet at the same $99 per month[2], while the AgelessRx intranasal spray runs $199 per month at 1000 mcg/mL[3]. The nasal form has no cold-chain requirement, which matters for Alaska and Hawaii patients.

Do either of these require blood work?

No, and that is a weakness in both. Embody states no bloodwork is required[2] and AgelessRx does not require baseline IGF-1 or include labs in its price. Baseline IGF-1 before prescribing is the correct standard for a GHRH analog. Patients at either provider should arrange their own baseline draw and a 90-day retest.

Does AgelessRx treat women?

Yes. AgelessRx prescribes to men and women aged 30 and over, with exclusions for untreated hypothyroidism, diabetes or hyperglycemia, liver and kidney disease, cancer history, and pregnancy. Embody is built specifically around female hormone optimization, with sermorelin prescribed alongside bioidentical estrogen and progesterone protocols[2] and a full female hormone panel at intake.

Can I cancel either program without a penalty?

Yes at both. Embody offers cancel-anytime terms, a 100% refund if not eligible, and no price increases[2]. AgelessRx has no membership fee, no minimum term, and cancels on 48 hours notice. Neither commits a patient beyond the current month, which is worth knowing on a therapy where sleep changes show at 2 to 4 weeks but body composition takes a full 6 months to judge.

References

  1. AgelessRx Sermorelin: product page (injection from $99/month, no membership or consultation fee, free shipping, 503A compounding pharmacies, asynchronous physician review, patients 30 and over, all 50 states) agelessrx.com, 2026. https://agelessrx.com/agelessrx_product/sermorelin/
  2. Embody Sermorelin Therapy: product page (from $99/month, no insurance or bloodwork required, licensed U.S. pharmacy, weekly injection and daily tablet forms, cancel anytime) sermorelin.joinem.co, 2026. https://sermorelin.joinem.co/
  3. AgelessRx Sermorelin Nasal Spray: product page (intranasal sermorelin from $199/month at 1000 mcg/mL, no cold-chain requirement, non-injectable delivery form) agelessrx.com, 2026. https://agelessrx.com/sermorelin-nasal-spray/
  4. Khorram O, Laughlin GA, Yen SS Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women J Clin Endocrinol Metab, 1997. PMID 9141536. https://pubmed.ncbi.nlm.nih.gov/9141536/